Literature DB >> 27037155

Erratum to: Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial.

Tzu-Hsien Tsai1, Cheng-Hsien Lu2, Christopher Glenn Wallace3, Wen-Neng Chang2, Shu-Feng Chen2, Chi-Ren Huang2, Nai-Wen Tsai2, Min-Yu Lan2, Pei-Hsun Sung1, Chu-Feng Liu4, Hon-Kan Yip5,6,7,8.   

Abstract

Entities:  

Year:  2016        PMID： 27037155      PMCID： PMC4818475          DOI： 10.1186/s13054-016-1256-y

Source DB:  PubMed          Journal:  Crit Care        ISSN： 1364-8535            Impact factor:   9.097


× No keyword cloud information.
Unfortunately, the original version of this article [1] contained an error. The date of clinical trial registration for this study was 10th January 2011, not 10th October 2008 as reported in the original article.
  1 in total

1.  Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial.

Authors:  Tzu-Hsien Tsai; Cheng-Hsien Lu; Christopher Glenn Wallace; Wen-Neng Chang; Shu-Feng Chen; Chi-Ren Huang; Nai-Wen Tsai; Min-Yu Lan; Pei-Hsun Sung; Chu-Feng Liu; Hon-Kan Yip
Journal:  Crit Care       Date:  2015-02-25       Impact factor: 9.097
  1 in total
  1 in total

Review 1.  Erythropoietin, a multifaceted protein with innate and adaptive immune modulatory activity.

Authors:  Chiara Cantarelli; Andrea Angeletti; Paolo Cravedi
Journal:  Am J Transplant       Date:  2019-04-25       Impact factor: 8.086
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.